Literature DB >> 6490466

Differential inhibitory effect of isoproterenol on contractions of canine airways.

J A Russell.   

Abstract

We examined the inhibitory effect of isoproterenol on contractions of isolated canine airways induced by histamine, 5-hydroxytryptamine (5-HT), and acetylcholine. Airway contractions were matched by using agonist concentrations that produced approximately 60% of the contractile force generated during a previous exposure to 10(-4) M acetylcholine. Concentrations of isoproterenol causing 50% relaxations of histamine-, 5-HT-, and acetylcholine-induced contractions were 9.9 X 10(-9), 3.6 X 10(-8), and 9.0 X 10(-8) M, respectively. Total relaxation of histamine- and 5-HT-induced contractions occurred at 10(-7) and 10(-6) M isoproterenol, respectively, whereas isoproterenol concentrations greater than or equal to 10(-4) M never totally relaxed airways contracted by acetylcholine. We conclude that isoproterenol inhibits airway contractions induced by histamine and 5-HT much more effectively than those induced by acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490466     DOI: 10.1152/jappl.1984.57.3.801

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  9 in total

Review 1.  Heterogeneity in epithelium-dependent responses.

Authors:  K Stuart-Smith
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Differential inhibitory effects of forskolin, isoproterenol, and dibutyryl cyclic adenosine monophosphate on phosphoinositide hydrolysis in canine tracheal smooth muscle.

Authors:  J M Madison; J K Brown
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

3.  Effects of muscarinic M2 and M3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro.

Authors:  N Watson; R M Eglen
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Modulation of agonist-induced phosphoinositide metabolism, Ca2+ signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms.

Authors:  B H Hoiting; H Meurs; M Schuiling; R Kuipers; C R Elzinga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

5.  Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum.

Authors:  H Reddy; N Watson; A P Ford; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

6.  No evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea.

Authors:  A F Roffel; H Meurs; C R Elzinga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

7.  Differential actions of AlF4- and vanadate on canine trachealis muscle.

Authors:  S H Lee; T H Hwang; J S Jung
Journal:  Pflugers Arch       Date:  1994-06       Impact factor: 3.657

Review 8.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

Review 9.  Does coupling to ADP ribosylation factor 6 explain differences between muscarinic and other receptors in interaction with β-adrenoceptor-mediated smooth muscle relaxation?

Authors:  Betül R Erdogan; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-02-17       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.